BORRONI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 29.973
AS - Asia 16.075
EU - Europa 12.288
SA - Sud America 3.791
AF - Africa 414
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 29
Totale 62.610
Nazione #
US - Stati Uniti d'America 29.463
SG - Singapore 5.463
CN - Cina 5.175
BR - Brasile 3.158
UA - Ucraina 2.451
DE - Germania 2.419
HK - Hong Kong 2.028
IT - Italia 1.873
VN - Vietnam 1.192
GB - Regno Unito 919
FR - Francia 917
PL - Polonia 875
RU - Federazione Russa 828
FI - Finlandia 817
TR - Turchia 527
IE - Irlanda 451
BD - Bangladesh 440
IN - India 386
AR - Argentina 262
CA - Canada 221
MX - Messico 173
SE - Svezia 134
IQ - Iraq 133
NL - Olanda 128
ID - Indonesia 115
ZA - Sudafrica 108
BE - Belgio 102
EC - Ecuador 97
JP - Giappone 91
AT - Austria 89
PK - Pakistan 75
ES - Italia 70
CO - Colombia 66
NG - Nigeria 64
CZ - Repubblica Ceca 62
MA - Marocco 62
SA - Arabia Saudita 60
VE - Venezuela 56
PY - Paraguay 55
UZ - Uzbekistan 53
CL - Cile 46
AU - Australia 36
KE - Kenya 33
EG - Egitto 27
IL - Israele 27
TN - Tunisia 27
KR - Corea 26
LT - Lituania 25
NP - Nepal 24
AE - Emirati Arabi Uniti 23
JO - Giordania 23
PH - Filippine 23
EU - Europa 22
JM - Giamaica 22
IR - Iran 21
KZ - Kazakistan 21
PE - Perù 21
DO - Repubblica Dominicana 19
MY - Malesia 18
UY - Uruguay 18
AZ - Azerbaigian 17
DZ - Algeria 17
MU - Mauritius 17
LB - Libano 16
RO - Romania 16
TH - Thailandia 15
TW - Taiwan 14
BG - Bulgaria 13
CR - Costa Rica 12
ET - Etiopia 12
SN - Senegal 11
BH - Bahrain 10
BY - Bielorussia 10
CH - Svizzera 10
HN - Honduras 10
PS - Palestinian Territory 10
GT - Guatemala 9
LV - Lettonia 9
CI - Costa d'Avorio 8
EE - Estonia 8
PA - Panama 8
AL - Albania 7
BO - Bolivia 7
XK - ???statistics.table.value.countryCode.XK??? 7
DK - Danimarca 6
HU - Ungheria 6
KW - Kuwait 6
NI - Nicaragua 6
RS - Serbia 6
TT - Trinidad e Tobago 6
AM - Armenia 5
BB - Barbados 5
HR - Croazia 5
NO - Norvegia 5
OM - Oman 5
PT - Portogallo 5
SV - El Salvador 5
CG - Congo 4
GD - Grenada 4
GE - Georgia 4
Totale 62.516
Città #
Fairfield 3.708
Singapore 2.870
Woodbridge 2.817
Ashburn 2.545
Hong Kong 2.020
Houston 1.910
Jacksonville 1.774
Seattle 1.470
Cambridge 1.348
Ann Arbor 1.322
Wilmington 1.243
San Jose 1.107
The Dalles 1.043
Beijing 980
Warsaw 863
Princeton 787
New York 740
Nanjing 645
Chandler 626
Lauterbourg 486
Los Angeles 472
Helsinki 450
Dublin 448
Ho Chi Minh City 444
Istanbul 430
Dallas 413
Dearborn 325
Milan 312
Munich 283
São Paulo 276
Buffalo 250
Nanchang 247
Moscow 239
Hanoi 235
Des Moines 234
Brescia 230
Redondo Beach 198
Shenyang 178
Changsha 174
San Diego 172
Council Bluffs 155
Shanghai 154
Chicago 150
San Francisco 137
Frankfurt am Main 136
Hebei 135
Jinan 130
Santa Clara 119
London 117
Tianjin 112
Nuremberg 111
Turku 106
Rio de Janeiro 102
Rome 102
Jiaxing 98
Brussels 95
Orem 95
Lancaster 93
Brooklyn 88
Belo Horizonte 85
Kunming 84
Boardman 76
Tokyo 74
Hangzhou 70
Toronto 70
Phoenix 68
Guangzhou 66
Denver 65
Montreal 64
Abuja 59
Zhengzhou 55
Atlanta 54
Mexico City 54
Verona 53
Haiphong 52
Johannesburg 52
Ningbo 50
Chennai 49
Norwalk 49
Tashkent 49
San Mateo 45
Curitiba 44
Baghdad 42
Brasília 42
Dhaka 42
Manchester 42
Nürnberg 42
Porto Alegre 42
Stockholm 41
Amsterdam 39
Da Nang 38
Mumbai 38
Vienna 38
Taizhou 37
Charlotte 36
Quito 36
Romola 36
Augusta 35
Biên Hòa 34
Naples 34
Totale 40.630
Nome #
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 425
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 327
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. 320
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 308
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 266
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 260
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 258
COVID-19 impact on consecutive neurological patients admitted to the emergency department 255
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 253
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 247
A complicated case of intracranial hypotension: Diagnostic and management strategies 245
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 238
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 231
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 230
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 226
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 226
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 222
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 219
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 219
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 213
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 209
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 208
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 208
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 207
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 206
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 203
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 202
A case report: doctor, my daughter has Alzheimer's disease. 201
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 200
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 199
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 198
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 195
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 191
A complicated case of intracranial hypotension: diagnostic and management strategies. 190
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 186
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 186
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 185
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 185
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 183
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 183
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 181
Autoimmunity and frontotemporal dementia 181
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 180
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 180
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 179
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 179
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 178
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 176
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 174
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 173
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 171
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 169
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 169
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 169
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 169
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 169
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 168
Acombination of CSF tau ratio and midsaggital midbraintopons atrophy for the earlydiagnosis of progressive supranuclear palsy 167
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 167
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 167
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 167
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 166
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38. 166
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 165
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 165
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 164
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 164
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 164
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 163
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 163
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 162
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 162
Vascular risk factors and cognition in Parkinson's disease 161
Revisiting brain reserve hypothesis in frontotemporal dementia: evidence from a brain perfusion study. 160
Cardiac arrhythmias and silent myocardial ischaemia in Mild Cognitive Impairment and Alzheimer Disease 160
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 158
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 158
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 157
Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. 156
Alterazioni del flusso ematico cerebrale nella Malattia di Alzheimer 155
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 154
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 153
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 152
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 152
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. 152
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. 152
New insights into the genetic etiology of Alzheimer’s disease and related dementias 151
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 151
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 151
Natural history and predictors of survival in progressive supranuclear palsy. 151
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 151
Cardiovascular structural and functional changes in Mild Cognitive Impairment and Alzheimer Disease.Potential predictive role of QT Dispersion and Heart Rate Variability Analysis 150
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 150
Anodal transcranial direct current stimulation of parietal cortex enhances action naming in Corticobasal Syndrome. 150
Endothelial nitric oxide synthase polymorphisms as risk factors for migraine: a response. 149
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 149
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 149
Left parietal cortex transcranial direct current stimulation enhances gesture processing in corticobasal syndrome. 149
Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch. 149
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 149
Totale 18.829
Categoria #
all - tutte 301.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 301.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021257 0 0 0 0 0 0 0 0 0 0 0 257
2021/20223.171 213 539 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20243.243 169 72 289 209 107 499 111 117 950 65 58 597
2024/20259.056 79 50 88 1.262 1.015 729 824 255 934 775 1.835 1.210
2025/202619.611 1.720 2.801 1.735 3.089 1.415 1.213 2.692 806 1.238 1.610 1.266 26
Totale 63.423